Growth factors and cytokines: Function and molecular regulation in pituitary adenomas

Frontiers of Hormone Research

Volumn 32, Issue , 2004, Pages 96-109

  Renner, Ulrich ^a   Paez Pereda, Marcelo ^a   Arzt, Eduardo ^a   Stalla, Günter K ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GROWTH PROMOTOR;

ADENOMA; ANIMAL; HUMAN; HYPOPHYSIS TUMOR; METABOLISM; PATHOPHYSIOLOGY; REVIEW;

ADENOMA; ANIMALS; CYTOKINES; GROWTH SUBSTANCES; HUMANS; PITUITARY NEOPLASMS;

EID: 4043049591     PISSN: 03013073     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000079039     Document Type: Article

References (59)

1. Renner U, Pagotto U, Arzt E, Stalla GK: Autocrine and paracrine roles of polypeptide growth factors, cytokines and vasoactive substances in normal and tumorous pituitary function and growth: A review. Eur J Endocrinol 1996;135:515-532.
2. Ray D, Melmed S: Pituitary cytokine and growth factor expression and action. Endocr Rev 1997; 18:206-228.
3. Arzt E, Paez Pereda M, Ferez Castro C, Pagotto U, Renner U, Stalla GK: Pathophysiological role of the cytokine network in the anterior pituitary gland. Front Neuroendocrinol 1999;20:71-95.
4. Asa SL, Ezzat S: The cytogenesis and pathogenesis of pituitary adenomas. Endocr Rev 1998;19: 798-827.
5. Asa SL, Ezzat S: The pathogenesis of pituitary tumours. Nat Rev 2002;2:836-849.
6. Masague J, Blain SW, Lo RS: TGF-β signaling in growth control, cancer and heritable disorders. Cell 2000;103:295-309.
7. Hentges S, De A, Pastorcic M, Boyadjieva N, Sarkar DK: Opposing effects of two TGF-β isoforms on pituitary lactotropic cell proliferation. Endocrinology 2000;141:1528-1535.
8. Pastorcic M, De A, Boyadjieva N, Vale W, Sarkar DK: Reduction in the expression and action of transforming growth factor-β, on lactotrophs during estrogen-induced tumorigenesis. Cancer Res 1995;55:4892-4898.
9. Hentges S, Sarkar DK: Transforming growth factor-β regulation of estradiol-induced prolactinomas. Front Neuroendocrinol 2001;22:340-363.
10. Hentges S, Boyadjieva N, Sarkar DK: Transforming growth factor-β3 stimulates lactotrope cell growth by increasing basic fibroblast growth factor from folliculo-stellate cells. Endocrinology 2000; 141:859-867.
11. Renner U, Lohrer P, Schaaf L, Feirer M, Schmitt K, Onofri C, Arzt E, Stalla GK: Transforming growth factor-β stimulates vascular endothelial growth factor production by folliculostellate pituitary cells. Endocrinology 2000; 143:3759-3765.
12. Weiss J, Harris PE, Halvorson LM, Crowley WF Jr, Jameson JL: Perfusion of rat pituitary cells with gonadotropin-releasing hormone, activin, and inhibin reveals distinct effects on gonadotropin gene expression and secretion. Endocrinology 1993;132:2307-2311.
13. Matzuk MM : Editorial: In search of binding - Identification of inhibin receptors. Endocrinology 2000; 141:2281-2284.
14. Hashimoto O, Nakamura T, Shoji H, Shimasaki S, Hayashi Y, Sugino H: A novel role of follistatin, an activin-binding protein, in the inhibition of activin action in rat pituitary cells. Endocytotic degradation of activin and its acceleration by follistatin associated with cell-surface heparan sulfate. J Biol Chem 1997;272:13835-13842.
15. Danila DC, Inder WJ, Zhang X, Alexander JM, Swearingen B, Hedley-Whyte ET, Klibanski A: Activin effects on neoplastic proliferation of human pituitary tumors. J Clin Endocrinol Metab 2000;85:1009-1015.
16. Zhou Y, Sun H, Danila DC, Johnson SR, Sigai DP, Zhang X, Klibanski A: Truncated activin type I receptor Alk4 isoforms are dominant negative receptors inhibiting activin signaling. Mol Endocrinol 2000; 14:2066-2075.
17. Penabad JL, Bashey HM, Asa SL, Haddad G, Davis KD, Herbst AB, Gennarelli TA, Kaiser UB, Chin WW, Snyder PJ: Decreased follistatin gene expression in gonadotroph adenomas. J Clin Endocrinol Metab 1996;81:3397-3403.
18. Treier M, Gleiberman AS, O'Connell SM, Szeto DP, McMahon JA, McMahon AP, Rosenfeld MG: Multistep signaling requirements for pituitary organogenesis in vivo. Genes Dev 1998;12: 1691-1704.
19. Scully KM, Rosenfeld MG: Pituitary development: Regulatory codes in mammalian organogenesis. Science 2002;295:2231-2235.
20. Paez-Pereda M, Giacomini D, Refojo D, Carbia Nagashima A, Hopfner U, Grübler Y, Chervin A, Goldberg V, Goya R, Hentges ST, Low MJ, Holsboer F, Stalla GK, Arzt E: Involvement of bone morphogenetic protein 4 in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk. Proc Natl Acad Sci USA 2003;100:1034-1039.
21. Roh M, Paterson AJ, Asa SL, Chin E, Kudlow JE: Stage-sensitive blockade of pituitary somatomammotrope development by targeted expression of a dominant negative epidermal growth factor receptor in transgenic mice. Mol Endocrinol 2001;15:600-613.
22. Kontogeorgos G, Stefaneanu L, Kovacs K, Cheng Z: Localization of epidermal growth factor and epidermal growth factor receptor in human pituitary adenomas and nontumorous pituitaries: An immunocytochemical study. Endocr Pathol 1996;7:63-70.
23. LeRiche VK, Asa SL, Ezzat S: Epidermal growth factor and its receptor (EGF-R) in human pituitary adenomas: EGF-R correlates with tumor aggressiveness. J Clin Endocrinol Metab 1996; 81:656-662.
24. Ezzat S, Zheng L, Smyth HS, Asa SL: The c-erbB-2/neu proto-oncogene in human pituitary tumours. Clin Endocrinol 1997;46:599-606.
25. Nose-Alberti V, Mesquita MI, Martin LC, Kayath MJ: Adrenocorticotropin-producing pituitary carcinoma with expression of c-erbB-2 and high PCNA index: A comparative study with pituitary adenomas and normal pituitary tissues. Endocr Pathol 1998;9:53-62.
26. Finley EL, Ramsdell JS: A transforming growth factor-a pathway is expressed in GH4C1 rat pituitary tumors and appears necessary for tumor formation. Endocrinology 1994;135:416-422.
27. McAndrew J, Paterson AJ, Asa SL, McCarthy KJ, Kudlow JE: Targeting of transforming growth factor-a expression to pituitary lactotrophs in transgenic mice results in selective lactotroph proliferation and adenomas. Endocrinology 1995;136:4479-4488.
28. Borgundvaag B, Kudlow JE, Mueller SG, George SR: Dopamine receptor activation inhibits estrogen-stimulated transforming growth factor-a gene expression and growth in anterior pituitary, but not in uterus. Endocrinology 1992;130:3453-3458.
29. Galzie Z, Kinsella AR, Smith JA: Fibroblast growth factors and their receptors. Biochem Cell Biol 1997;75:669-685.
30. Heaney AP, Horwitz GA, Wang Z, Singson R, Melmed S: Early involvement of estrogen-induced pituitary tumor transforming gene and fibroblast growth factor expression in prolactinoma patho-genesis. Nat Med 1999;5:1317-1321.
31. Zimering MB, Katsumata N, Sato Y, Brandi ML, Aurbach GD, Marx SJ, Friesen HG: Increased basic fibroblast growth factor in plasma from multiple endocrine neoplasia type 1 : Relation to pituitary tumor. J Clin Endocrinol Metab 1993;76:1182-1187.
32. Ezzat S, Smyth HS, Ramyar L, Asa SL: Heterogenous in vivo and in vitro expression of basic fibroblast growth factor by human pituitary adenomas. J Clin Endocrinol Metab 1995;80:878-884.
33. Asa SL, Ramyar L, Murphy PR, Li AW, Ezzat S: The endogenous fibroblast growth factor-2 antisense gene product regulates pituitary cell growth and hormone production. Mol Endocrinol 2001;15:589-599.
34. Asghar Abbass SA, Asa SL, Ezzat S: Altered expression of fibroblast growth factor receptors in human pituitary adenomas. J Clin Endocrinol Metab 1997;82:1160-1166.
35. Ezzat S, Zheng L, Zhu XF, Wu GE, Asa SL: Targeted expression of a human pituitary tumor-derived isoform of FGF receptor-4 recapitulates pituitary tumorigenesis. J Clin Invest 2002; 109:69-78.
36. Low MJ: Pituitary adenomas in man and mouse: Oncogenic potential of a truncated fibroblast growth factor receptor 4. J Clin Invest 2002;109:15-16.
37. Missale C, Boroni F, Losa M, Giovanelli M, Zanellato A, Dal Toso R, Balsari A, Spano P: Nerve growth factor suppresses the transforming phenotype of human prolactinomas. Proc Natl Acad Sci USA 1993;90:7961-7965.
38. Missale C, Losa M, Sigala S, Balsari A, Giovanelli M, Spano PF: Nerve growth factor controls proliferation and progression of human prolactinoma cell lines through an autocrine mechanism. Mol Endocrinol 1996; 10:272-285.
39. Fiorentini C, Guerra N, Facchetti M, Finardi A, Tiberio L, Schiaffonati L, Spano P, Missale C: Nerve growth factor regulates dopamine D2 receptor expression in prolactinoma cell lines via p75NGFR-mediated activation of nuclear factor-KB. Mol Endocrinol 2002; 16:353-366.
40. Missale C, Spano P: Nerve growth factor in pituitary development and pituitary tumors. Front Neuroendocrinol 1998;19:128-150.
41. Arzt E: gp130 cytokine signaling in the pituitary gland: A paradigm for cytokine-neuroendocrine pathways. J Clin Invest 2001;108:1729-1733.
42. Castro CP, Giacomini D, Nagashima AC, Onofri C, Graciarena M, Kobayashi K, Paez-Pereda M, Renner U, Stalla GK, Arzt E: Reduced expression of the cytokine transducer gp130 inhibits hormone secretion, cell growth, and tumor development in pituitary lactosomatotrophic GH3 cells. Endocrinology 2003; 144:693-700.
43. Hanisch A, Dieterich KD, Dietzmann K, Lüdecke K, Buchfelder M, Fahlbusch R, Lehnert H: Expression of members of the interleukin-6 family of cytokines and their receptors in human pituitary and pituitary adenomas. J Clin Endocrinol Metab 2000;85:4411-4414.
44. Renner U, Gloddek J, Paez Pereda M, Arzt E, Stalla GK: Regulation and role of intrapituitary IL-6 production by folliculostellate cells. Dornest Anim Endocrinol 1998;15:353-362.
45. Jones TH, Daniels M, James RA, Justice SK, McCorkle R, Price A, Kendall-Taylor P, Weetman AP: Production of bioactive and immunoreactive interleukin-6 (IL-6) and expression of IL-6 messenger ribonucleic acid by human pituitary adenomas. J Clin Endoccrinol Metab 1994;78: 180-187.
46. Paez Pereda M, Lohrer P, Kovalovsky D, Perez Castro C, Goldberg V, Losa M, Chervin A, Berner S, Molina H, Stalla GK, Renner U, Arzt E: Interleukin-6 is inhibited by glucocorticoids and stimulates ACTH secretion and POMC expression in human corticotroph pituitary adenomas. Exp Clin Endocrinol Diabetes 2000; 108:202-207.
47. Arzt E, Buric R, Stelzer G, Stalla J, Sauer J, Renner U, Stalla GK: Interleukin (IL) involvement in anterior pituitary cell growth regulation: Effects of IL-2 and IL-6. Endocrinology 1993;132: 459-467.
48. Paez Pereda M, Goldberg V Chervin A, Carrizo G, Molina A, Andrada J, Sauer J, Renner U, Stalla GK, Arzt E: Interleukin (IL)-2 and IL-6 regulate c-fos protooncogene expression in human pituitary adenoma explants. Mol Cell Endocrinol 1996;124:33-42.
49. Auernammer CJ, Melmed S: Leukemia inhibitory factor - neuroimmune modulator of endocrine function. Endocr Rev 1999;21:313-345.
50. Yano H, Readhead C, Nakashima M, Ren SG, Melmed S: Pituitary-directed leukemia inhibitory factor transgene causes Cushing's syndrome: Neuro-immune-endocrine modulation of pituitary development. Mol Endocrinol 1998; 12:1708-1720.
51. Kontogeorgos G, Patralexis H, Tran A, Kovacs K, Melmed S: Expression of leukemia inhibitory factor in human pituitary adenomas: A morphologic and immunocytochemical study. Pituitary 2000;2:245-251.
52. Ben-Shlomo A, Miklovsky I, Ren SG, Yong WH, Heaney AP, Culler MD, Melmed S: Leukemia inhibitory factor regulates prolactin secretion in prolactinoma and lactotroph cells. J Clin Endocrinol Metab 2003;88:858-863.
53. Heaney AP, Fernando M, Melmed S: Functional role of estrogen in pituitary tumor pathogenesis. J Clin Invest 2002;109:277-283.
54. Oishi Y, Okuda M, Takahashi H, Fujii T, Morii S: Cellular proliferation in the anterior pituitary gland of normal adult rats: Influence of sex, estrous cycle, and circadian change. Anat Rec 1993;235:111-120.
55. Yin P, Arita J: Differential regulation of prolactin release and lactotrope proliferation during pregnancy, lactation and the estrous cycle. Neuroendocrinology 2000;72:72-79.
56. Orgnero de Gaisan E, Maldonado CA, Aoki A: Fate of degenerating lactotropes in rat pituitary gland after interruption of lactation: A histochemical and immunocytochemical study. Histochem J 1993;25:150-165.
57. Aoki A, de Gaisan EO, Pasolli HA, Torres AI: Disposal of cell debris from surplus lactotrophs of pituitary gland. Exp Clin Endocrinol Diabetes 1996; 104:256-262.
58. Drewett N, Jacobi JM, Willgoss DA, Lloyd HM: Apoptosis in the anterior pituitary gland of the rat: Studies with estrogen and bromocriptine. Neuroendocrinology 1993;57:89-95.
59. Kovacs K, Stefaneanu L, Ezzat S, Smyth HS: Prolactin-producing pituitary adenoma in a maleto-female transsexual patient with protracted estrogen administration. A morphological study. Arch Pathol Lab Med 1994;118:562-565.